Package Label (10mg Bottle Label)
Tadalafil Tablet, Film Coated
Product Images NDC 67184-0523
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 67184-0523). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Qilu Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label (10mg Cart)
This text provides information about Tadalfil tablets, USP, with 10 mg strength. The tablets should not be split and the entire dose should be taken. The package contains 90*46*15mm size tablets with NDC number 67184-0525-2. The text includes some illegible characters and symbols and does not provide any additional information about the medication.*
Package Label (20mg Bottle Label)
This appears to be a description of a medication named "Tadaldfil Tablets, USP." It comes in a pack of 30 tablets and is only available with a prescription. The NDC number is listed as 67184-0526-1. There are some symbols and characters that are not readable, so the description may be incomplete or inaccurate.*
Package Label (20mg Cart)
This is a description of a drug called Tadalaofil Tablets, USP. The tablets come in a specific size of 90*46*15mm and have a National Drug Code of 67184-0526-2. Each tablet comprises of 20mg Alafil. The tablets should not be split and the entire dosage should be taken. The remaining text is not readable.*
Package Label (2point5mg Bottle Label)
This is the description of a medication. The medication comes in the form of 30 tablets, each containing 25mg of the active ingredient. It is intended for once daily use and should not be split. The manufacturer is Qilu Pharmaceutical (Hainan) Co. Ltd, located in Haikou, China. Further information about the medication can be found using the NDC number provided: NDC 67184-0523-1. The given text does not provide any information on the name or purpose of the medication.*
Package Label (2point5mg Carton Label)
This appears to be a label/box of Tadalafil tablets. The dimensions of the box are 90%67*20mm, and it contains 30 tablets, divided into two cards, each with 15 tablets. Each tablet contains Tadalafil. There are two types of tablets: Tadalafil Tablets, USP for once-daily use and 25mg Tadalafil Tablets, USP, which are prescription-only medicines. The rest of the text is not readable due to errors.*
Package Label (5mg Bottle Label)
Tadalafil Tablets, USP are available in 30 tablet bottle with NDC 67184-0524-1. These tablets should not be shared and entire dose should be taken. The manufacturer of these tablets is Qi Pharmaceutical located in Haikou, 57031. This is a prescription-only medication (Rx only).*
Package Label (5mg Cart)
Description: This is a label for Tadalafil tablets that come in a pack of 30 tablets. Each tablet contains 5 mg of Tadalafil, which is used for once-daily use. The measurement of the tablets is 90 x 67 x 20mm.*
Figure (F001)
Figure (F002)
Figure (F003)
Figure (F004)
This is a graph that demonstrates the plasma concentration of Tadalafil in micrograms per liter over time when administered in different doses. The graph shows the concentration for a single 20mg dose of Tadalafil (represented by a solid line), a single 5mg dose of Tadalafil (represented by a dotted line), and once-daily 5mg Tadalafil following five consecutive days of administration (represented by a dashed line). The x-axis represents the time in hours, while the y-axis represents the plasma concentration in micrograms per liter.*
Figure 5 (F005)
The text describes a graph or chart showing the change in IPSS total score over the weeks of treatment. The treatment options are Tadalafil Tablets 5 mg and Placebo. The graph shows that there is no change at the start of treatment (week 0), but a significant improvement is observed in the Tadalafil group after 3 weeks of treatment compared to the Placebo group. The improvement continues to increase over a period of 12 weeks.*
Figure 6 (F006)
The text describes the results of a study comparing the IPSS Total Score between a group of patients taking Tadalafil Tablets 5mg and those taking a placebo. The text provides a graph depicting the results with a statistically significant difference between the two groups (p<0.01). The duration of treatment in weeks is also indicated.*
Figure 7 (F007)
Figure 8 (F008)
This is a report on IPSS Total Score, a measure used in evaluating the severity of lower urinary tract symptoms in men. The report shows the scores for patients who were treated with Tadalafil Tablets 5 mg or placebo for an unspecified duration of weeks. A significant difference was observed between the two treatment groups (p<0.01). The text contains some illegible characters.*
Chemical Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
